Urologix ULGX Stock
Urologix Price Chart
Urologix ULGX Financial and Trading Overview
| Urologix stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 1.0E-5 - 0.0002 USD |
| Volume | 800 USD |
| Avg. Volume | 6.12K USD |
| Market Cap | 82.91K USD |
| Beta (5Y Monthly) | -82.4743 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ULGX Valuation Measures
| Enterprise Value | 4.84M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0069094924 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.404 |
| Enterprise Value/EBITDA | -12.982 |
Trading Information
Urologix Stock Price History
| Beta (5Y Monthly) | -82.4743 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0002 USD |
| 52 Week Low | 1.0E-5 USD |
| 50-Day Moving Average | 0.0001194 USD |
| 200-Day Moving Average | 0.00010485 USD |
ULGX Share Statistics
| Avg. Volume (3 month) | 6.12K USD |
| Avg. Daily Volume (10-Days) | 80 USD |
| Shares Outstanding | 21.82M |
| Float | N/A |
| Short Ratio | 1.02 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 41.23K |
| Short % of Float | 0.29% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2014 |
| Most Recent Quarter (mrq) | March 31, 2015 |
| Next Fiscal Year End | June 30, 2015 |
Profitability
| Profit Margin | -38.90% |
| Operating Margin (ttm) | -7.28% |
| Gross Margin | 47.12% |
| EBITDA Margin | -3.10% |
Management Effectiveness
| Return on Assets (ttm) | -7.62% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 12M USD |
| Revenue Per Share (ttm) | 0.56 USD |
| Quarterly Revenue Growth (yoy) | -16.69% |
| Gross Profit (ttm) | 5.9M USD |
| EBITDA | -373000 USD |
| Net Income Avi to Common (ttm) | -4668000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 492K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 5.33M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.555 |
| Book Value Per Share (mrq) | -0.379 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -263000 USD |
| Levered Free Cash Flow (ttm) | 725.88K USD |
Profile of Urologix
| Country | United States |
| State | MN |
| City | Minneapolis |
| Address | 14405 21st Avenue North |
| ZIP | 55447 |
| Phone | 763 475 1400 |
| Website | https://www.urologix.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 61 |
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
Q&A For Urologix Stock
What is a current ULGX stock price?
Urologix ULGX stock price today per share is 0.0001 USD.
How to purchase Urologix stock?
You can buy ULGX shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Urologix?
The stock symbol or ticker of Urologix is ULGX.
Which industry does the Urologix company belong to?
The Urologix industry is Medical Devices.
How many shares does Urologix have in circulation?
The max supply of Urologix shares is 829.07M.
What is Urologix Price to Earnings Ratio (PE Ratio)?
Urologix PE Ratio is now.
What was Urologix earnings per share over the trailing 12 months (TTM)?
Urologix EPS is -0.01 USD over the trailing 12 months.
Which sector does the Urologix company belong to?
The Urologix sector is Healthcare.